Therefore, we analyzed our recent ChIP-seq data exploring genome-wide binding sites of GRHL2 in three luminal human breast cancer cell lines (MCF-7, T47D, and BT474) and three basal A human breast cancer cell lines (HCC1806, BT20, and MDA-MB-468).40 This evidence concerns the gene GRHL2 and breast carcinoma.